Ocean Power Technologies to Release Fiscal 2025 Second Quarter Early Earnings on December 2, 2024
MONROE TOWNSHIP, N.J., Nov. 18, 2024 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (“OPT” or “the Company”) (NYSE American: OPTT), a […]
CleanCore Solutions, Inc. (ZONE) Launches Pilot Program with International Hotel Chain
Omaha, NE, Nov. 18, 2024 (GLOBE NEWSWIRE) — CleanCore Solutions, Inc. (NYSE American: ZONE) (“CleanCore” or the “Company”), developer of […]
FOXO TECHNOLOGIES INC.’S BOARD OF DIRECTORS ANNOUNCES SPECIAL MEETING OF SHAREHOLDERS
MINNEAPOLIS, MN, Nov. 18, 2024 (GLOBE NEWSWIRE) — FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), will hold a […]
Foremost Clean Energy Announces Strategic Engagement with Red Cloud Financial Services
VANCOUVER, British Columbia, Nov. 18, 2024 (GLOBE NEWSWIRE) — Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the […]
Draganfly Announces Pricing of US$3.76 Million Registered Direct Offering
Saskatoon, SK., Nov. 18, 2024 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), […]
CSW Industrials Updates Share Repurchase Program
DALLAS, Nov. 18, 2024 (GLOBE NEWSWIRE) — CSW Industrials, Inc. (Nasdaq: CSWI) today announced its Board of Directors authorized a […]
Dario Pressimone Joins Edible Garden as Vice President of Digital and E-Commerce
BELVIDERE, NJ, Nov. 18, 2024 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), […]
Brad Edgar Joins Stifel as Managing Director and Lead Healthcare Equity Trader
ST. LOUIS, Nov. 18, 2024 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today announced the hiring of Brad Edgar […]
Nano Dimension Reminds Shareholders that Time Is Running Out to Protect Their Investment – Vote FOR Nano’s Proposals
Deadline is Fast Approaching on Sunday, December 1st, 2024, at 11:59 p.m. ET Shareholders Should Call Their Brokers Today to Ensure […]
Aclaris Therapeutics Announces $80 Million Private Placement
WAYNE, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) (the “Company” or “Aclaris”), a clinical-stage biopharmaceutical […]
